Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Bill Nichols Jr.
Person

Bill Nichols Jr.

Tracked across 2 events · 12 articles · First seen May 19, 2026 · Last active Aug 20, 2026

Sentiment
25
Attention
3
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
3 50
Business
Protagenic Therapeutics Engages Regulatory, Operations Advisors
Impact: Bill Nichols Jr., President of AnBogen Therapeutics, expressed confidence in the strategic engagements, highlighting the expertise of Dr. Eric Floyd and the capabilities of Danforth Health.
May 19, 2026 · 6 articles
2 0
Regulatory
FDA pre-IND feedback for PT00114
AnBogen Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company, announced on August 20, 2026, that it received written responses from the U.S. United States — Food and Drug Administration (FDA) to its Type B pre-Investigational New…
Impact: Bill Nichols Jr., President of AnBogen Therapeutics, commented on the FDA feedback, emphasizing the company's progress and the potential of PT00114's mechanism. His statements reflect management's optimism and strategic direction.
Aug 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Bill Nichols Jr. live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.